GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinohealth Holdings Ltd (HKSE:02361) » Definitions » Revenue

Sinohealth Holdings (HKSE:02361) Revenue : HK$446.5 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sinohealth Holdings Revenue?

Sinohealth Holdings's revenue for the six months ended in Jun. 2024 was HK$171.7 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was HK$446.5 Mil. Sinohealth Holdings's Revenue per Share for the six months ended in Jun. 2024 was HK$0.41. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$1.06.

During the past 12 months, the average Revenue per Share Growth Rate of Sinohealth Holdings was 8.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 24.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 5 years, Sinohealth Holdings's highest 3-Year average Revenue per Share Growth Rate was 30.10% per year. The lowest was 24.10% per year. And the median was 27.10% per year.


Sinohealth Holdings Revenue Historical Data

The historical data trend for Sinohealth Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinohealth Holdings Revenue Chart

Sinohealth Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
197.79 239.54 396.93 398.30 433.35

Sinohealth Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Revenue Get a 7-Day Free Trial Premium Member Only 142.08 262.94 158.54 274.81 171.74

Competitive Comparison of Sinohealth Holdings's Revenue

For the Health Information Services subindustry, Sinohealth Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinohealth Holdings's Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sinohealth Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Sinohealth Holdings's Revenue falls into.


;
;

Sinohealth Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$446.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinohealth Holdings  (HKSE:02361) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Sinohealth Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Sinohealth Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinohealth Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Wangjiang Second Street, Room 1111, Huangge Town, Nansha District, Guangdong Province, Guangzhou City, CHN
Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.
Executives
Futu Trustee Limited 2301 Trustee
Shanghai Tianyi Assets Management Co., Ltd 2201 Interest of corporation controlled by you
Yu Rong 2201 Interest of corporation controlled by you
Tianyi (bvi) Limited 2101 Beneficial owner
Shang Hai Xuan Yu Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Rikan Industry Investment Limited Partnership
Wang Lifang 2201 Interest of corporation controlled by you
Wu Yushu 2201 Interest of corporation controlled by you
Wlf Investment Holdings Limited 2101 Beneficial owner
Li Hanxiong 2201 Interest of corporation controlled by you
Montesy Capital Holding Ltd 2101 Beneficial owner
Wu Meirong 2202 Interest of your spouse
Ying Lian You Xian Gong Si 2101 Beneficial owner

Sinohealth Holdings Headlines

No Headlines